Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

Bluemn, Eric G., Coleman, Ilsa M., Lucas, Jared M., Coleman, Roger T., Hernandez-Lopez, Susana, Tharakan, Robin, Bianchi-Frias, Daniella, Dumpit, Ruth F. +19 more·2017·Cancer Cell

DOI 10.1016/j.ccell.2017.09.003

Cited by (744)

Items 601–700 of 744

Deoxynortryptoquivaline: A unique antiprostate cancer agent
Yohko Momose Yamazaki, Manabu Kawada, Isao Momose · 2023 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Evaluation of the Expression EGFR, HER2/NEU and the End Effector ERK of the RAS/RAF/MAP Kinase Pathway in Prostatic Adenocarcinoma for a Possible Role as New Target Therapy
Asem Ali Shalaby, Heba Mahmoud, Shayma Sayed, Khalid Al Hashmi, Shadia Al-Sinawi, Suad Al Badi, Afrah Al Rashdi, Samya Al Husaini, Hajer Al Badi, Somaia A. Saad El-Din · 2024 · Asian Pacific Journal of Cancer Prevention
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308
Shaghayegh Nouruzi, Fraser D. Johnson, Sahil Kumar, Olena Sivak, Nakisa Tabrizian, Milla Koistinaho, Anu Muona, Amina Zoubeidi · 2024 · Oncology Reports
Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey‐Holden Prostate Cancer Academy Meeting
Andrea K. Miyahira, Marina Nasrin Sharifi, Lisa N. Chesner, Asmaa El-Kenawi, Roni Haas, Laura A. Sena, Alok K. Tewari, Kenneth J. Pienta, Howard R. Soule · 2024 · The Prostate
Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
Renée de Leeuw, Qi Cao, Hung‐Ming Lam · 2020 · Frontiers in Oncology
Transcriptional Inactivation of TP53 and the BMP Pathway Mediates Therapy-induced Dedifferentiation and Metastasis in Prostate Cancer
Hyunho Han, Yan Wang, Josué Curto, Sreeharsha Gurrapu, Sara Laudato, Alekya Rumandla, Goutam Chakraborty, Xiaobo Wang, Hong Chen, Yan Jiang et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Cancer-driven IgG promotes the development of castration-resistant Prostate Cancer though the SOX2-CIgG pathway
Caipeng Qin, Zhengzuo Sheng, Xinmei Huang, Jingshu Tang, Yang Liu, Tao Xu, Xiaoyan Qiu · 2020
Editorial: The development of lethal prostate cancer
Baotong Zhang, Sifeng Qu, Xin Li, Xinpei Ci, Chang Jiang · 2023 · Frontiers in Cell and Developmental Biology
First, do no harm: The unclear benefit of lifelong castration for patients with metastatic prostate cancer
Laura A. Sena, Hao Wang, Samuel Ray Denmeade · 2023 · The Prostate
Clinically relevant humanized mouse models of metastatic prostate cancer to evaluate cancer therapies
Raymond J. Kostlan, John T. Phoenix, Audris Budreika, Marina G. Ferrari, Neetika Khurana, Jae Eun Cho, Kristin M. Juckette, Brooke L. McCollum, Russell Moskal, Rahul Mannan et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer
Larysa Poluben, Mannan Nouri, Jiaqian Liang, Andreas S. Varkaris, Betul Ersoy-Fazlioglu, Olga S. Voznesensky, Irene I. Lee, Xintao Qiu, Laura Cato, Ji-Heui Seo et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancer
Shipra Shukla, Dan Li, Holly M. Nguyen, Jennifer A. Conner, Gabriella Bayshtok, Woo Hyun Cho, Mohini R. Pachai, Nicholas A. Teri, Eric Campeau, Sarah Attwell et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer
Shan Li, Kai Song, Huiyun Sun, Yong Tao, Arthur J. Y. Huang, Vipul Bhatia, Brian P. Hanratty, Radhika A. Patel, Henry W. Long, Colm M. Morrissey et al. · 2025 · eLife
Increasing Cancer Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival
Xiaozhuo Liu, Anmbreen Jamroze, Eduardo Cortes, Yibing Ji, Kathy Zhao, Faming Zhao, Julian Ho, Yang Seagle Liu, Elai Davicioni, Shan Wu et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
EZH2 alters aggressive variant prostate cancer subtype evolution, but is not required for neuroendocrine prostate cancer
Justine J. Jacobi, Kristine M. Wadosky, Neha Jaiswal, Xiaojing Zhang, Yanqing Wang, Prashant K. Singh, Jie Wang, Eduardo Cortes Gomez, Jianmin Wang, Bo Xu et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer
Beatriz German, Katherine L. Morel, Teia Noel, Nadia Boufaied, Deborah L. Burkhart, Sujun Chen, Felipe Segato Dezem, Xintao Qiu, Henry W. Long, Stefan DiFazio et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
ProMPt: A modular preclinical platform for functional modelling of prostate cancer heterogeneity and therapeutic vulnerabilities
Nicole Pandell, Jacob Househam, Matteo Tartagni, Archana P. Thankamony, Florian Gabel, Roberto Rota, Elizabeth Flittner, Bora Gürel, Ines Figueiredo, George Seed et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Molecular decoupling of lineage identity and morphology in aggressive variant prostate cancer
Chennan Li, JuanJuan Yin, Melissa L. Abel, Dana S. Vargas Solivan, Kinjal P. Bhadresha, Sumeyra Kartal, Samantha Nichols, Kanak Parmar, Joseph D. Twohig, Tri M. Truong et al. · 2026 · medRxiv
Chromatin reprogramming as adaptation mechanism in advanced prostate cancer
Alfonso Urbanucci · 2018 · European Urology Supplements
Targeting CD133 In Androgen Receptor Indifferent, Neuroendocrine Differentiated Aggressive Variant Prostate Cancer
Paige M. Glumac · 2019 · University of Minnesota Digital Conservancy (University of Minnesota)
The prostate cancer stem cell niche: Genetic drivers and therapeutic approaches
Giacomo Canesin · 2020 · Advances in stem cells and their niches
Performance evaluation of the KRYPTOR Compact PLUS analyzer-based B.R.A.M.S CgA II KRYPTOR assay for chromogranin A measurement
Yu Jeong Choi, Juhye Roh, Sinyoung Kim, Kyung-A Lee, Younhee Park · 2021 · Research Square
“ IL1B loss is associated with increased AR activity in castration-resistant prostate cancer”
Wisam N. Awadallah, Jagpreet Singh Nanda, Sarah E. Kohrt, Magdalena M. Grabowska · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Faculty Opinions recommendation of Genomic correlates of clinical outcome in advanced prostate cancer.
Alvin M. Matsumoto · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Identifying Potential Off-Target Protein Binders of Glutamate-Ureido-Lysine, a Prostate Cancer Specific Imaging Agent
Martin K. Bakht, John J. Hayward, Farsheed Shahbazi‐Raz, Daniel L. Meister, Adam Pillon, Mathew Stover, Adam Tronchin, Lavleen K. Mader, Bre‐Anne Fifield, Sheng‐Yu Ku et al. · 2020 · ChemRxiv
Faculty Opinions recommendation of Enzalutamide Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors.
Brion William Murray · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.
Charlotte Lynne Bevan, Theodora A. Constantin · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Hormone -Refractory Prostatic Adenocarcinoma Mimicking Basal Cell Carcinoma: A Case Report
Justin E. Caron, Steven D. Hart, Karim Chamie, Huihui Ye · 2020 · AJSP Review and Reports
Androgen and Estrogen Receptor Signaling
Xiaoxiang Guan, Runtian Wang · 2022 · Elsevier eBooks
S-nitrosoglutathione Inhibits the Growth of Androgen-Receptor Dependent and Castration Resistant Prostate Cancer by Modulating FOXM1 Signaling
Anastasia Vedenko, Khushi Hemendra Shah, Derek Van Booven, Fakiha Fridaus, Deepa Seetham, Himanshu Arora, Joshua M. Hare, Ranjith Ramasamy · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
A NOVEL UNBIASED SEED-BASED RNAi SCREEN IDENTIFIES SMALL RNAs THAT INHIBIT ANDROGEN SIGNALING AND PROSTATE CANCER CELL GROWTH
Joshua M. Corbin, Constantin Georgescu, Lin Wang, Jonathan D. Wren, Magdalena Bieniasz, Chao Xu, Adam Steven Asch, María Jesús Ruiz-Echevarría · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Reprint of: de novo neuroendocrine features in prostate cancer
Eman Abdulfatah, Samson W. Fine, Tamara Levin Lotan, Rohit Mehra · 2023 · Human Pathology
Data from Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
Matti Annala, Sinja Taavitsainen, Daniel Joseph Khalaf, Gillian Rae Vandekerkhove, Kevin Beja, Joonatan Sipola, Evan W. Warner, Cameron Herberts, Amanda Wong, Simon Yuen Fai Fu et al. · 2023
Data from A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer
Yara Rodríguez, Kenji Unno, Mihai Ioan Truica, Zachary Rockow Chalmers, Young A. Yoo, Rajita J. Vatapalli, Vinay Sagar, Jindan Yu, Barbara Lysy, Maha Hussain et al. · 2023
Data from SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer
Rafael S. Martinez, Mark J. Salji, Linda K. Rushworth, Chara Ntala, Giovanny Rodriguez Blanco, Ann Hedley, William Clark, Paul Peixoto, Éric Hervouet, Elodie Renaude et al. · 2023
Data from Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer
Ali Ghoochani, En‐Chi Hsu, Merve Aslan, Meghan A. Rice, Holly M. Nguyen, James D. Brooks, Eva Corey, Ramasamy Paulmurugan, Tanya Ivanova Stoyanova · 2023
Data from Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer
Rachana Patel, Elspeth A. Brzezińska, Peter Repiščák, Imran Ahmad, Ernest J. Mui, Meiling Gao, Arnaud Blomme, Victoria J. Harle, Ee Hong Tan, Gaurav Malviya et al. · 2023
Data from Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide
Landon Carter Brown, Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Zelig Szmulewitz, Daniel Costin Danila, Ethan S. Barnett et al. · 2023
Data from Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
Ilsa M. Coleman, Navonil De Sarkar, Colm M. Morrissey, Li Xin, Martine P. Roudier, Erolcan Sayar, Dapei Li, Eva Corey, Michael C. Haffner, Peter S. Nelson · 2023
Supplementary Data 3 from Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer
Jonathan R. Branch, Tammy L. Bush, Vineet Pande, Peter J. Connolly, Zhuming Zhang, Ian Hickson, Janine Ondrus, Steffen Jaensch, James Robert Bischoff, Georges Habineza et al. · 2023
Data from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
Navonil De Sarkar, Robert D. Patton, Anna-Lisa Doebley, Brian P. Hanratty, Mohamed Adil, Adam J. Kreitzman, Jay F. Sarthy, Minjeong Ko, Sandipan Brahma, Michael P. Meers et al. · 2023
Data from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
Navonil De Sarkar, Robert D. Patton, Anna-Lisa Doebley, Brian P. Hanratty, Mohamed Adil, Adam J. Kreitzman, Jay F. Sarthy, Minjeong Ko, Sandipan Brahma, Michael P. Meers et al. · 2023
Data from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
Lucie Van Emmenis, Sheng‐Yu Ku, Kaitlyn M. Gayvert, Jonathan R. Branch, Nicholas J. Brady, Subhasree Basu, Mike R. Russell, Joanna Cyrta, Aram Vosoughi, Verena Wilbeth Sailer et al. · 2023
A expressão dos marcadores de transição epitélio-mesenquimal SNAI1 e o ZEB1 resulta em alterações transcricionais para promover progressão tumoral e evasão imune no câncer de próstata
Luiz Paulo Chaves · 2023
Data from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
Michael D. Nyquist, Ilsa M. Coleman, Jared M. Lucas, Dapei Li, Brian P. Hanratty, Hannah E. Meade, Elahe A. Mostaghel, Stephen R. Plymate, Eva Corey, Michael C. Haffner et al. · 2023
Data from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
Michael D. Nyquist, Ilsa M. Coleman, Jared M. Lucas, Dapei Li, Brian P. Hanratty, Hannah E. Meade, Elahe A. Mostaghel, Stephen R. Plymate, Eva Corey, Michael C. Haffner et al. · 2023
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Partha P. Banerjee, Shiv K. Srivastava · 2023 · Springer eBooks
Recent updates in the evaluation of histopathological characteristics of prostate cancer
Martina G Stoeva · 2023 · Varna Medical Forum
Loss of ERRγ promotes lineage plasticity towards neuroendocrine prostate cancer
Vincent Giguère, Ting Li, Catherine R. Dufour, Lingwei Han · 2024 · Research Square
RFX6 at locus 6q22 confers metastasis and drug resistance in prostate cancer
Mengjie Zhong, Wenjie Xu, Pan Wen Tian, Qin Zhang, Zixian Wang, Limiao Liang, Qixiang Zhang, Yuehong Yang, Ying Lü, Gong-Hong Wei · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Acute sensorimotor paraneoplastic neuropathy in a patient with small cell prostate cancer
Marco Faggin, Brendan McCann, Paul Gallagher, Jonathan M. Salmond · 2024 · BMJ Case Reports
Role of Nanotrace Element in Prostate Cancer an Update
Nancy Jenifer, J.W Evelyn Rainy, Janaki Velmurugan · 2023 · Journal of Cancer and Tumor International
An Extracellular Matrix Overlay Model for Bioluminescence Microscopy to Measure Single-Cell Heterogeneous Responses to Antiandrogens in Prostate Cancer Cells
Audrey Champagne, Imen Chebra, Pallavi Jain, Cassandra Ringuette Goulet, Annie Lauzier, Antoine Guyon, Bertrand Neveu, Frédéric Pouliot · 2024 · Biosensors
Aggressive variant prostate cancer with multiple subcutaneous metastases: a case report
Yusuke Hoshino, Kent Kanao, Yu Miyama, Takeo Kosaka, Go Kaneko, Suguru Shirotake, Masanori Yasuda, Masafumi Oyama · 2024 · International Cancer Conference Journal
Metabolic enzymes moonlighting to drive enzalutamide resistance in prostate cancer
Maria Rusan, Simone Weiss, Karina Dalsgaard Sørensen · 2024 · Translational Andrology and Urology
The Molecular Biology of Prostate Cancer: Diagnosis, Resistance and Virulence
Reinand Thompson, Samuel Essa, Martin Marcus · 2024 · SciBase oncology.
Investigating the role of mitochondrial energy rewiring throughout prostate cancer progression
Charles L. Bidgood · 2023 · Queensland University of Technology
Computational Analysis of Treatment Resistant Cancer Cells
Alexandre Matov · 2024 · medRxiv
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Partha P. Banerjee, Shiv K. Srivastava · 2024 · Springer eBooks
Autocrine fibroblast growth factor receptor 1 signaling activates lactate dehydrogenase A-aerobic glycolysis for human prostate cancer DU145 cell growth
Xiaoming Xu, Tianjun Peng, Wang Li, Jiaren Pan, Huafeng Pan, Tingitng Gu, Zhongliang Cheng, Jianting Zhang · 2024 · Research Square
Role of kallikreins in prostate cancer
Mahasweta Ghosh, Pujayita Devgupta, Dibyapriya Roy Chowdhury, Kausik Mondal, Tapati Chakraborti, Sajal Chakraborti · 2024 · Elsevier eBooks
Prostate Cancer and Tumor Microenvironment
Ahmad Nazari, Parisa Osati, Nazanin Pazhouhesh Far, Al‐Hasnawi Rasool Riyadh Abdulwahid, Ferdos Faghihkhorasani, Nasim Ebrahimi, Mostafa Haji-Fatahaliha, Amir Reza Aref · 2024 · Springer eBooks
Prostate Cancer and Metastasis: An Emphasis on EMT Mechanism
Mehrdad Hashemi, Shima Hajimazdarany, Reza Morovatshoar, Abbas Amini, Amirsoheil Karami, Alireza Hajimohammad, Zahra Zare, Anis Mashhad Merdasi, Hosein Izadi, Saba Asadi et al. · 2024 · Springer eBooks
Neuroendocrine prostate cancer (clinical case)
G. A. Khakimov, Гулноз Голибовна Хакимова, S. F. Dallo, Shakhnoz G. Khakimova, A. M. Khakimov · 2024 · Medical alphabet
Cell Models of Castration Resistant and High Dose Testosterone-Resistant Prostate Cancer Recapitulate the Heterogeneity of Response Observed in Clinical Practice
Laura S Graham, Lih‐Jen Su, Andrew Nicklawsky, Frances Xiuyan Feng, David J. Orlicky, Joseph Petraccione, Maren Salzmann‐Sullivan, Steven K. Nordeen, Thomas W. Flaig · 2025 · Cancers
5th edition of the 2022 WHO classification of prostate cancer: changes and novelties in the "Blue Book"
Hana Sedláčková, Ivan Trávníček, Adriena Bartoš Veselá, Tomáš Pitra, Milan Hora, Ondřej Fiala, Kristýna Pivovarčíková · 2023 · Česká urologie
IRE1 activity regulates tumour and microenvironment cell lineage states while stratifying localised and metastatic prostate cancer
Dimitrios Doultsinos, Ingrid Tomljanović, Eleftherios D. Pilalis, Sophia M. Abusamra, Romuald Parmentier, I.E. Bridges, Sandy Figiel, Yanis Zekri, Joanna Hester, Damien A. Leach et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Targeting anti-androgen therapy resistance through epigenetic rewiring
Kate E. Dunmore, David S. Rickman · 2025 · Nature Cancer
Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression
Yibo Meng, Jianchao Ge, Cheng Zhou, Hangbin Ma, Chenchen Chen, Yinghao Zhou, Xuetao Hu, Yaozong Xu, Xilong Wang, Guowei Shi et al. · 2025 · Journal of Cancer Research and Clinical Oncology
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer
Shan Li, Kai Song, Huiyun Sun, Yong Tao, Arthur J. Y. Huang, Vipul Bhatia, Brian P. Hanratty, Radhika A. Patel, Henry W. Long, Colm M. Morrissey et al. · 2025 · eLife
In Vitro and In Silico Evaluation of the Potential Anti-Prostate Cancer Activity of Rosmarinus officinalis L. Leaf Extracts
Samantha Franchette B. Austria, Mon‐Juan Lee, Kathlia A. De Castro-Cruz, Pang‐Hung Hsu, Cheng-Yang Hsieh, Steven Kuan-Hua Huang, Po‐Wei Tsai · 2025 · International Journal of Molecular Sciences
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancer
Marjorie L. Roskes, Alexander Martinez‐Fundichely, Sandra M. Cohen, Metin Balaban, Chen Khuan Wong, Weiling Li, Tonatiuh A. Gonzalez, Anisha B. Tehim, Hao Xu, Shahd ElNaggar et al. · 2025 · medRxiv
PRMT5:MEP50 Are Mediators of Treatment‐Induced Neuroendocrine Differentiation in Prostate Cancer
Hye Seung Nam, Andrew Michael Asberry, Xuehong Deng, Sheng Liu, Jiaoti Huang, Chang‐Deng Hu, Jun Wan, Michael K. Wendt · 2025 · The Prostate
Impact of Metastatic Microenvironment on Physiology and Metabolism of Small Cell Neuroendocrine Prostate Cancer Patient-Derived Xenografts
Shubhangi Agarwal, Deepti Upadhyay, Jinny Sun, Emilie Decavel-Bueff, Robert Bok, Romelyn Delos Santos, Said Al Muzhahimi, Rosalie Nolley, Jason C. Crane, John V. Kurhanewicz et al. · 2025 · Cancers
Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer
Jude N. Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben, Carla Calagua, Christopher M. Dennehy, Anastasia-Maria Stavridi, Liyang Wang, Olga S. Voznesensky, Fang Xie, Huihui Ye et al. · 2025 · Clinical Cancer Research
TRIM24 Degradation Counteracts Adaptation to Androgen Receptor Inhibition in Prostate Cancer
Daniela Bossi, Arianna Vallerga, Giuseppe Salfi, Nicolò Formaggio, Valentina Ceserani, Zhang Jichang, Tiziano Bernasocchi, Andrea Rinaldi, Lukas Bubendorf, Simone Mosole et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Nonbone Metastasis in Prostate Cancer: Characteristics, Tumor Microenvironment, Diagnosis and Treatment
Genyu Du, Penghui Xu, Helen He Zhu, Na Jing · 2025 · Cancer Heterogeneity and Plasticity
PDGFC facilitates enzalutamide resistance in prostate cancer through activation of the Rap1-MAPK pathway
Bingqian Deng, Saipeng Chen, Dan Zhong, Guojing Song, Heting Liu, Langlang Xie, Youxin Liu, Rongrong Ni, Wenhao Shen, Gang Huang · 2025 · Journal of Cancer Research and Clinical Oncology
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer
Komal Sharma, Divin A. Wilson, Yu Wang, Shabi Haider, Vineel Bhatlapenumarthi, Daniel Boiarsky, John M. Cipriaso, Leo Yermakov, Raja Ram Dutta, Manavita Vashisth et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Demethylmycemycin A, a dibenzoxazepinone from the marine-derived Dactylosporangium sp. OK1079, with prostate cancer suppressive effects via targeting BRK-FAK-STAT3 axis
Marwa Elsbaey, Md. Towhidul Islam Tarun, Radwan A. Alnajjar, Takahiro Jomori, Junichi Tanaka, Naoya Oku, Khalid A. El Sayed, Yasuhiro Igarashi · 2025 · The Journal of Antibiotics
Disruption of NUAK2-Mediated RNA Splicing by Trilaciclib Reveals a Therapeutic Vulnerability in AR-Indifferent Prostate Cancer
Umar Mehraj, Uran Maimekov, Shaista Manzoor, Emily Cordova, Manasiben Patel, Ikeer Y. Mancera-Ortiz, Stefanie Howell, Zachary W. Davis‐Gilbert, Mu‐En Wang, Ming Chen et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Epidemiology and treatments of neuroendocrine prostate cancer in a large commercially insured population in the US
Zdravko P. Vassilev, Qayyim Said, Jihong Zong, Nasreen Khan, Christine Rentzsch, Gal Barel, Lorelei Ann Mucci, Orsolya E. Lunacsek · 2025 · Cancer Treatment and Research Communications
Therapy-induced PSMA2 Sensitizes Prostate Cancer Cells to Residual Androgen and Promotes Neuroendocrine Lineage Transformation
Nadia Patterson, Andrei Badoi, Gangadhara Prasadachari Vadla, M Hasani, J Moyer, C De la Nuez Ramirez, Chiswili Yves Chabu · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Heterogeneous High-Dose Testosterone Resistance in CRPC: Three Novel Cell Models Recapitulate Clinical Variability
S. Benali, M. Khedidja, A. Tarek · 2025 · Asian journal of Current Research in Clinical Cancer
Additional file 1 of Epigenetic mechanisms underlying prostate cancer radioresistance
Macedo-Silva, Catarina, Benedetti, Rosaria, Ciardiello, Fortunato, Cappabianca, Salvatore, Jerónimo, Carmen, Lucia Altucci · 2021 · Figshare
Additional file 1 of Characterization and validation of long noncoding RNAs as new candidates in prostate cancer
Ge, Shengyang, Mi, Yuanyuan, Zhao, Xiaojun, Hu, Qingfeng, Guo, Yijun, Fan Zhong, Zhang, Yang, Xia, Guowei, Sun, Chuanyu · 2020 · Figshare
Research Advances in Neuroendocrine Prostate Cancer
雪迎刘 · 2025 · Bioprocess
p21 CIP1/WAF1 -mediated partial senescence supports steroidogenesis and therapy resistance in primary prostate cancer cultures
Emily Toscano, Valentina Maggio, Jose G. Alvarez-Meythaler, Javier Garcia, A. Celma, Jacques Planas, María Eugenia Semidey, Mercedes Marín‐Aguilera, Rosa Somoza, Begoña Mellado et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer
Toshiki Oka, Koji Hatano, Shohei Katsuki, Tomohiro Kanaki, Shunsuke Inoguchi, Masaru Tani, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi et al. · 2026 · Cancer Science
ADT and activation of HGF and WNT axes in double-null prostate cancer
Dexter Hoi Long Leung, Yao Mawulikplimi Adzavon, Gaeul Chu, Tae Ju Park, Kristoffer Nikias, Cheong-Wun Kim, Chenmiao Liu, Zijie Sun · 2026 · Nature Reviews Urology
Gene expression inference from cell-free DNA using uncertainty-aware deep learning
Robert D. Patton, A. Patrick McDeed, Alexander Netzley, Aditya Pawar, Thomas W. Persse, Akira Nair, Patricia C. Galipeau, Ilsa M. Coleman, Pushpa Itagi, Pooja Chandra et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Production of Human Prostate Adenocarcinoma Tumoroids for Antitumor Testing
Patrícia Lima Falcão, Carlos Roberto Jorge Soares · 2026 · IntechOpen eBooks
Therapeutic interference of SREBP-mediated lipid metabolism by E-Xanthohumol attenuates prostate cancer progression
Jonathan Viehoever, Naveen Surya Velmani, Vignesh Basavaraj, Lahiru Gamage, Kai-Cheng Chan, Praveenkumar Basavaraj, Wen‐Chin Huang · 2026 · Biochemical Pharmacology
Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer
Yu-Wei Chen, Joanne Xiu, Kelsey Anne Poorman, Charles J. Ryan, Brady Gilg, Matthew James Oberley, Gloria Hopkins Sura, George W. Sledge, Shuang G. Zhao, Alan Tan et al. · 2026 · JCO Precision Oncology
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer
Allison Makovec, John T. Phoenix, Hannah E. Bergom, Ella Boytim, Ava P. Gustafson, Aiden Deacon, Sydney Tape, Atef Mir Ali, Megan Ludwig, Samuel P. Pitzen et al. · 2026 · Oncotarget
Cellular and molecular mechanisms underlying the role played by the MEN1 gene in prostate cancer cells
Yakun Luo · 2021 · theses.fr (ABES)
A Pleiotropic Role of the SWI/SNF Complex in Cancer – Insights From Two Tumor Types : Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Prostatic Carcinoma
Joanna Cyrta · 2020
Rôle de la signalisation calcique et de la transition épithélio-mésenchymateuse dans l’agressivité et la différenciation neuroendocrine du cancer de la prostate
Fanny Bery · 2021
The role played by MEN1 in breast cancer and the underlying mechanisms : crosstalk between menin, ERα and MYC
Razan Abou Ziki · 2021
Caractérisation et ciblage thérapeutique de progéniteurs luminaux impliqués dans le cancer de la prostate résistant à la castration
Manon Baurès · 2023